Skip to main content
SHIELD THERAPEUTICS PLC logo

SHIELD THERAPEUTICS PLC — Investor Relations & Filings

Ticker · STX ISIN · GB00BYV81293 LEI · 213800G74QWY15FC3W71 IL Manufacturing
Open in API
Filings indexed 408 across all filing types
Latest filing 2020-10-19 Regulatory Filings
Country GB United Kingdom
Listing IL STX

About SHIELD THERAPEUTICS PLC

https://www.shieldtherapeutics.com/

Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Withdrawal of all oppositions by TEVA
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a formal announcement dated October 19, 2020, regarding the withdrawal of opposition proceedings by Teva Pharmaceutical Industries Ltd concerning Shield Therapeutics' patents. This type of brief, time-sensitive corporate update, distributed via the RNS system (the news service of the London Stock Exchange), fits the definition of a general regulatory announcement that doesn't specifically map to financial reports (10-K, IR), management changes (MANG), or specific shareholder actions (DIV, DVA). Since it is a general regulatory news item distributed through the official channel, the most appropriate classification is Regulatory Filings (RNS). The document length is short (4647 chars), but it is reporting a definitive event outcome rather than announcing the future publication of a report, so RPA is less suitable than RNS.
2020-10-19 English
Block Listing 6 Monthly Return
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with 'RNS Number' and contains boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and compliance with the Financial Conduct Authority. The content itself is a 'Block Listing 6 Monthly Return' detailing the balance of unallotted securities under various share plans for the period from March 6, 2020, to September 30, 2020. This type of routine regulatory update, distributed via the RNS system, fits best under the general 'Regulatory Filings' category, as there is no specific code for a 'Block Listing Return' among the specialized options, and it is not a primary financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or SHA).
2020-09-30 English
Total Voting Rights Update
Regulatory Filings Classification · 98% confidence The document is explicitly marked with an 'RNS Number' and contains a 'Total Voting Rights Update' dated 30 September 2020. It states the total number of issued ordinary shares and confirms that no shares are held in treasury, referencing FCA's Disclosure and Transparency Rule 5.6.1. This type of mandatory regulatory disclosure regarding share capital and voting rights is a standard regulatory announcement. Given its nature as a short, mandatory update disseminated via the RNS system, it fits best under the general 'Regulatory Filings' category (RNS), as there is no specific code for 'Total Voting Rights Update' and it is not a comprehensive report like 10-K or IR. The document length is short (3605 chars), supporting the idea that it is an announcement rather than a full report.
2020-09-30 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report for the six months ended 30 June 2020' and contains detailed financial highlights, operational reviews, and management commentary regarding the company's performance for that specific period. It is a comprehensive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. H1 2020
2020-09-16 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 8030Y) from Shield Therapeutics plc. The core purpose of the announcement is to state that the company "will announce its interim results for the six months ended 30 June 2020 on Wednesday 16 September 2020" and to provide details for the subsequent analyst and investor briefings. Since the document itself is not the comprehensive Interim Report (IR) but rather an announcement about *when* the results will be released and how to attend the follow-up calls, it fits the definition of a Report Publication Announcement (RPA). It explicitly announces the publication of results and provides details for accessing related events/materials (briefings, Q&A, recording). The document length (5030 chars) is consistent with a short announcement rather than a full financial report.
2020-09-14 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (3588 characters) and its primary content is an announcement titled 'Total Voting Rights Update'. It explicitly states the total number of issued shares and confirms compliance with FCA's Disclosure and Transparency Rule 5.6.1. This type of mandatory, periodic disclosure regarding share capital structure and voting rights does not fit neatly into the specific categories like ER, IR, or 10-K. Since it is a formal regulatory announcement distributed via RNS (London Stock Exchange's news service), and it doesn't fit a more specific category like DIRS (Director's Dealing) or SHA (Share Issue/Capital Change, which usually implies a change, not just a periodic update), the most appropriate fallback category is Regulatory Filings (RNS).
2020-08-28 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.